Loading [MathJax]/extensions/MathMenu.js
Karanlığın hormonu: Melatonin
Year 2010 ,
Volume: 14 Issue: 3, 112 - 120, 06.03.2014
Goksel Şener
References
Ferguson SA, Rajaratnam SM, Dawson D. Melatonin ago- nists and insomnia. Expert Rev Neurother, 10: 305-318, 2010.
Lerne r AB, Case JD, Takahashi Y, Lee TH, Mori W. Iso- lation of melatonin, the pineal gland factor that lightens melanocytes. J Amer Chem Soc, 80: 2587, 1958
Hardeland R, Pandi-Perumal SR, Cardinali DP. Melatonin. Int J Biochem Cell Biol, 38: 313-316, 2006.
Reiter RJ, Melchiorri D, Sewerynek E, Poeggeler B, Barlow- Walden L, Chuang J, Ortiz GG, Acuña-Castroviejo D.A review of the evidence supporting melatonin’s role as an antioxidant. J Pineal Res, 19: 149-165, 1995.
Konturek SJ, Konturek PC, Brzozowska I, Pawlik M, Sli- wowski Z, Cześnikiewicz-Guzik M, Kwiecień S, Brzozows- ki T, Bubenik GA, Pawlik WW. Localization and biological activities of melatonin in intact and diseased gastrointesti- nal tract (GIT). J Physiol Pharmacol, 58: 381-405, 2007.
Reiter RJ, Carneiro RC, Oh C-S. Melatonin in relation to cellular antioxidative defense mechanisms. Horm Metab Res, 29: 363-372,1997.
Reiter RJ. Neuroendocrine effects of light. Int J Biometeo- rol, 35: 169-175, 1991.
Year 2010 ,
Volume: 14 Issue: 3, 112 - 120, 06.03.2014
Goksel Şener
References
Ferguson SA, Rajaratnam SM, Dawson D. Melatonin ago- nists and insomnia. Expert Rev Neurother, 10: 305-318, 2010.
Lerne r AB, Case JD, Takahashi Y, Lee TH, Mori W. Iso- lation of melatonin, the pineal gland factor that lightens melanocytes. J Amer Chem Soc, 80: 2587, 1958
Hardeland R, Pandi-Perumal SR, Cardinali DP. Melatonin. Int J Biochem Cell Biol, 38: 313-316, 2006.
Reiter RJ, Melchiorri D, Sewerynek E, Poeggeler B, Barlow- Walden L, Chuang J, Ortiz GG, Acuña-Castroviejo D.A review of the evidence supporting melatonin’s role as an antioxidant. J Pineal Res, 19: 149-165, 1995.
Konturek SJ, Konturek PC, Brzozowska I, Pawlik M, Sli- wowski Z, Cześnikiewicz-Guzik M, Kwiecień S, Brzozows- ki T, Bubenik GA, Pawlik WW. Localization and biological activities of melatonin in intact and diseased gastrointesti- nal tract (GIT). J Physiol Pharmacol, 58: 381-405, 2007.
Reiter RJ, Carneiro RC, Oh C-S. Melatonin in relation to cellular antioxidative defense mechanisms. Horm Metab Res, 29: 363-372,1997.
Reiter RJ. Neuroendocrine effects of light. Int J Biometeo- rol, 35: 169-175, 1991.
There are 7 citations in total.
Cite
APA
Şener, G. (2014). Karanlığın hormonu: Melatonin. Marmara Pharmaceutical Journal, 14(3), 112-120. https://doi.org/10.12991/mpj.85333
AMA
Şener G. Karanlığın hormonu: Melatonin. J Res Pharm. March 2014;14(3):112-120. doi:10.12991/mpj.85333
Chicago
Şener, Goksel. “Karanlığın Hormonu: Melatonin”. Marmara Pharmaceutical Journal 14, no. 3 (March 2014): 112-20. https://doi.org/10.12991/mpj.85333.
EndNote
Şener G (March 1, 2014) Karanlığın hormonu: Melatonin. Marmara Pharmaceutical Journal 14 3 112–120.
IEEE
G. Şener, “Karanlığın hormonu: Melatonin”, J Res Pharm , vol. 14, no. 3, pp. 112–120, 2014, doi: 10.12991/mpj.85333.
ISNAD
Şener, Goksel. “Karanlığın Hormonu: Melatonin”. Marmara Pharmaceutical Journal 14/3 (March 2014), 112-120. https://doi.org/10.12991/mpj.85333.
JAMA
Şener G. Karanlığın hormonu: Melatonin. J Res Pharm . 2014;14:112–120.
MLA
Şener, Goksel. “Karanlığın Hormonu: Melatonin”. Marmara Pharmaceutical Journal, vol. 14, no. 3, 2014, pp. 112-20, doi:10.12991/mpj.85333.
Vancouver
Şener G. Karanlığın hormonu: Melatonin. J Res Pharm. 2014;14(3):112-20.